Related Content
October 26, 2011 โ Lantheus Medical Imaging announced it has been awarded three-year supplier contracts with Premier ...
October 26, 2011
May 18, 2011 โ Lantheus Medical Imaging Inc. announced data from a phase 2 clinical trial that demonstrated positron ...
May 18, 2011
March 11, 2011 โ U.S. Food and Drug Administration (FDA) and Lantheus Medical Imaging Inc. today reached agreement on a ...
March 11, 2011
December 17, 2010 โ An ultrasound contrast agent is under review by the U.S. Food and Drug Administration (FDA) for use ...
December 17, 2010December 10, 2010 โ The first commercial production of generators using molybdenum-99 (Mo-99) produced with low-enriched ...
December 10, 2010
October 14, 2010 โ An injectable magnetic resonance angiography (MRA) blood pool imaging agent has been released in ...
October 14, 2010
July 16, 2010 โ Lantheus Medical Imaging Inc. this week announced the launch of its ultrasound contrast imaging agent ...
July 16, 2010
June 15, 2010 โ A new study evaluating the safety of an echocardiography contrast agent found that the agent did not ...
June 15, 2010
June 8, 2010 - Since August of 2009, Lantheus Medical Imaging has been exploring options to obtain additional molybdenum ...
June 08, 2010
June 4, 2010 โ The first national contract signed for a magnetic resonance imaging angiography (MRA) contrast agent was ...
June 03, 2010ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now